Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration

J. Y. Hwang, J. Lee, C. K. Oh, H. W. Kang, I. Y. Hwang, J. W. Um, H. C. Park, S. Kim, J. H. Shin, W. Y. Park, R. B. Darnell, H. D. Um, K. C. Chung, K. Kim, Y. J. Oh

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Cerebellar degeneration-related protein 2 (cdr2) is expressed in the central nervous system, and its ectopic expression in tumor cells of patients with gynecological malignancies elicits immune responses by cdr2-specific autoantibodies and T lymphocytes, leading to neurological symptoms. However, little is known about the regulation and function of cdr2 in neurodegenerative diseases. Because we found that cdr2 is highly expressed in the midbrain, we investigated the role of cdr2 in experimental models of Parkinson's disease (PD). We found that cdr2 levels were significantly reduced after stereotaxic injection of 1-methyl-4-phenylpyridinium (MPP+) into the striatum. cdr2 levels were also decreased in the brains of post-mortem PD patients. Using primary cultures of mesencephalic neurons and MN9D cells, we confirmed that MPP + reduces cdr2 in tyrosine hydroxylase-positive dopaminergic neuronal cells. The MPP+-induced decrease of cdr2 was primarily caused by calpain-and ubiquitin proteasome system-mediated degradation, and cotreatment with pharmacological inhibitors of these enzymes or overexpression of calcium-binding protein rendered cells less vulnerable to MPP+-mediated cytotoxicity. Consequently, overexpression of cdr2 rescued cells from MPP+-induced cytotoxicity, whereas knockdown of cdr2 accelerated toxicity. Collectively, our findings provide insights into the novel regulatory mechanism and potentially protective role of onconeural protein during dopaminergic neurodegeneration.

Original languageEnglish
Article numbere2240
JournalCell Death and Disease
Volume7
Issue number6
DOIs
Publication statusPublished - 2016 Jun 2

Bibliographical note

Funding Information:
This research was supported by the Mid-Career Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Science, and Technology (to YJO), and by the Brain Research Program through NRF funded by the Ministry of Science, ICT and Future Planning: 2014M3C7A1064545 to KCC and 2012M2A2A7010422 to H-DU. JL is a recipient of the Brain Research Program through the NRF funded by the Ministry of Science, ICT, and Future Planning (2013M3C7A1056731).

Publisher Copyright:
© 2016 Macmillan Publishers Limited All rights reserved.

All Science Journal Classification (ASJC) codes

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration'. Together they form a unique fingerprint.

Cite this